Trial Profile
The Effect of Montelukast on Inflammatory Responses of Nasal Epithelial Cells Cultured From Patients With Asthma, With and Without Concomitant Allergic Rhinitis.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Allergic rhinitis; Asthma
- Focus Pharmacodynamics
- 09 Nov 2010 New trial record